Addus HomeCare (NASDAQ:ADUS) EVP Sells $257,213.88 in Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Monica Raines sold 2,062 shares of the stock in a transaction dated Friday, November 6th. The shares were sold at an average price of $124.74, for a total transaction of $257,213.88. Following the sale, the executive vice president directly owned 13,577 shares in the company, valued at $1,693,594.98. This trade represents a 13.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Addus HomeCare Stock Down 1.4%

NASDAQ:ADUS opened at $123.72 on Friday. The firm has a market cap of $2.30 billion, a P/E ratio of 20.62, a P/E/G ratio of 1.65 and a beta of 0.75. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.64 and a current ratio of 1.64. Addus HomeCare Corporation has a fifty-two week low of $87.95 and a fifty-two week high of $131.59. The firm has a 50-day simple moving average of $118.30 and a two-hundred day simple moving average of $107.17.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.79 by $0.04. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The firm had revenue of $387.74 million for the quarter, compared to the consensus estimate of $388.72 million. During the same quarter in the prior year, the firm posted $1.56 earnings per share. The business’s revenue was up 7.0% on a year-over-year basis. Analysts predict that Addus HomeCare Corporation will post 6.41 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. UBS Group boosted their price objective on shares of Addus HomeCare from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, November 5th. Raymond James Financial set a $137.00 target price on Addus HomeCare in a research note on Monday, September 28th. Zacks Research raised Addus HomeCare from a “hold” rating to a “strong-buy” rating in a report on Tuesday. Barclays boosted their price target on Addus HomeCare from $96.00 to $101.00 and gave the stock an “underweight” rating in a research note on Wednesday, November 4th. Finally, Royal Bank Of Canada boosted their price target on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $136.33.

Institutional Trading of Addus HomeCare

Institutional investors have recently made changes to their positions in the stock. First Trust Advisors LP lifted its holdings in shares of Addus HomeCare by 21.9% during the 3rd quarter. First Trust Advisors LP now owns 39,432 shares of the company’s stock valued at $4,359,000 after buying an additional 7,084 shares during the period. Private Wealth Asset Management LLC bought a new stake in shares of Addus HomeCare in the third quarter worth $187,000. Private Advisor Group LLC grew its holdings in shares of Addus HomeCare by 15.5% in the third quarter. Private Advisor Group LLC now owns 2,940 shares of the company’s stock worth $325,000 after acquiring an additional 394 shares during the period. Boston Partners increased its position in Addus HomeCare by 18.0% during the third quarter. Boston Partners now owns 290,332 shares of the company’s stock valued at $32,222,000 after acquiring an additional 44,279 shares during the last quarter. Finally, Global Retirement Partners LLC increased its position in Addus HomeCare by 270.4% during the third quarter. Global Retirement Partners LLC now owns 900 shares of the company’s stock valued at $99,000 after acquiring an additional 657 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.